The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

John Ryan named senior vice president and general counsel at Dana-Farber

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

John Ryan was named senior vice president, general counsel and chief governance officer of Dana-Farber Cancer Institute.

Ryan began these roles Dec.1, 2020. Ryan has expertise representing health care and life sciences organizations in public company and non-profit settings. He has managed a range of legal matters, including medical research and technology, clinical care, IP protection and international expansion.

Ryan joins Dana-Farber from The Jackson Laboratory, where he was general counsel and corporate secretary. He previously held similar roles at Unilife Corp. and Aramark Corp., and was a partner at the Philadelphia-based law firm Duane Morris LLP.

Table of Contents

YOU MAY BE INTERESTED IN

Podcast

36 months to live, 29 months to wait. Why is Congress withholding lifesaving benefits from breast cancer patients?

In this episode of The Cancer Letter Podcast, Fran Visco, president of the National Breast Cancer Coalition, and Jacquelyn Cobb, managing editor of The Cancer Letter, discuss the Metastatic Breast Cancer Act, bipartisan legislation that would eliminate the waiting periods for Social Security Disability Insurance and Medicare for eligible people with metastatic breast cancer. 
Sponsored

The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer.

Congress settled the FY26 question in February, with NCI receiving $7.352 billion, an increase of $128 million over the prior year. After a year in which cancer center directors spent an extraordinary share of their leadership attention defending the research enterprise, that outcome deserves to be called what it was: a win.
By Jeff Sorenson
Obituary

Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel

Harold P. Freeman, a surgeon who started his career in Harlem, where, in addition to performing surgeries, he pioneered the system of patient navigation, and who studied health disparities and served as president of the American Cancer Society and chair of the President’s Cancer Panel, died on Aug. 11. He was 93.
By Paul Goldberg
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account